CCMP III’s investors include domestic and foreign public and corporate pension funds, sovereign wealth funds, insurance companies, foundations, endowments and high net worth individuals. The closing of CCMP III, the successor fund to the $3.4 billion CCMP Capital Investors II fund raised in 2006, brings the firm’s assets under management and committed capital to approximately $7.5 billion.
“We believe our firm has a unique model that integrates proprietary research, operating talent and investment acumen. At CCMP, we are fully focused on driving growth and returns through operational transformation. We believe this model is extraordinarily powerful and effective in generating alpha for our limited partners,” said Greg Brenneman, Chairman of CCMP.
CCMP specializes in making buyout and growth equity investments in the United States and Europe. The firm typically invests $100 million to $500 million of equity per transaction in companies with enterprise values of $500 million to $2 billion. Sectors of interest include consumer/retail, industrial, healthcare, and energy. CCMP is headquartered in New York (www.ccmpcapital.com).
“The success of this fundraise is a testament to our team’s 30-year track record of strong and consistent returns and the confidence and trust of our existing and new limited partners who are investing alongside us,” said Stephen Murray, President and CEO. “We are pleased with the construction and performance of the fund’s current portfolio and look forward to delivering outstanding returns for our investors.”
CCMP III has already invested in three companies as follows:
- Jamieson Laboratories, a branded provider of vitamin, mineral and supplement products in Canada;
- The Hillman Group, a distributor of fasteners, keys, engraveable tags and other hardware-related items primarily to the North American retail market; and,
- Jetro Cash & Carry, the largest cash and carry business-to-business retail foodservice operator in the United States.
The firm also recently announced an investment in Eco Services, the U.S. sulfuric acid virgin production and regeneration business of Solvay S.A., which is expected to close later this year.
2014 PEPD • Private Equity’s Leading News Magazine • 9-12-14